Table 1 Basic clinical and epidemic features based on Arbidol usage (two groups)
Feature | Without Arbidol (n = 90) | With Arbidol (n = 130) | p value |
|---|---|---|---|
Age [years, M (IQR)]a | 51 (44, 60) | 48 (37, 56) | 0.13 |
> 50 years (%) | 52 (57.8) | 59 (45.4) | 0.07 |
Male (%) | 47 (52.2) | 72 (55.4) | 0.64 |
Underlying disease (%)b | 16 (17.8) | 27 (20.8) | 0.58 |
Onset symptoms | |||
Fever (%) | 64 (71.1) | 112 (86.2) | 0.006 |
Less than 3 onset symptoms (%)c | 52 (57.8) | 82 (63.1) | 0.43 |
Lab examination | |||
WBC [× 109/L, M (IQR)] | 5.2 (4.4, 6.1) | 5.4 (4.3, 6.7) | 0.17 |
Neutrophils % [M (IQR)] | 66.5 (60.8, 70.2) | 62.9 (55.3, 71.9) | 0.22 |
Lymphocyte % [M (IQR)] | 23.4 (19.1, 28.6) | 23.4 (17.6, 32.1) | 0.28 |
Platelet [× 109/L, M (IQR)] | 164.0 (132.5, 219.5) | 166.5 (143.8, 211.3) | 0.86 |
CT Findings | |||
Lung region distribution | |||
Unilateral (%) | 2 (2.2) | 1 (0.8) | 0.36 |
Bilateral (%) | 88 (97.8) | 128 (98.4) | 0.71 |
Absence of lesion (%) | 0 (0.0) | 1 (0.8) | 0.4 |
Lesions feature | |||
GGOsd | 37 (41.1) | 65 (50) | 0.19 |
Scattered patchy infiltration with interstitial alteration | 39 (43.3) | 32 (24.6) | 0.004 |
Consolidation | 2 (2.2) | 7 (5.4) | 0.24 |
More than one feature | 12 (13.3) | 25 (19.2) | 0.25 |
Clinical types | |||
Mild type | 0 (0.0) | 1 (0.8) | 0.4 |
Common type | 90 (100.0) | 129 (99.2) | 0.4 |
Other treatments except for antiviral drugs | |||
Antibiotics | 54 (60.0) | 85 (65.4) | 0.42 |
Chinese medicine (Lian Hua Qing Wen) | 72 (80.0) | 108 (83.1) | 0.56 |
Methylprednisolone | 1 (1.1) | 1 (0.8) | 1 |
Gamma immunoglobulin | 1 (1.2) | 2 (1.5) | 1 |